ReviewCurrent obesity reports2026
PIEZO Channels in Metabolism and Metabolic Diseases: Research Advances and Therapeutic Strategies.
Review in Current obesity reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purpose of reviewThis review aims to summarize the current knowledge on the role of mechanical-gated ion channel PIEZO in body metabolism and metabolic diseases, as well as the latest evidence of PIEZO1 channels as a therapeutic strategy for metabolic diseases. RECENT
findingsPIEZO channels are mechanosensitive ion channels that play a crucial role in converting mechanical stimuli into biological signals. They participate in numerous physiological and pathological processes within the human body. Recently, the importance of PIEZO channels in body metabolism and metabolic diseases has garnered significant attention. This review summarizes the current status of research in carbohydrate and lipid metabolism, energy metabolism, and bone metabolism. It also examines the role and mechanisms of PIEZO channels in obesity, diabetes and its complications, osteoporosis, metabolic syndrome, and other diseases. Furthermore, we organize and discuss the potential for targeting PIEZO channels through multi-faceted therapeutic strategies to treat metabolic diseases. PIEZO channels play a crucial role in the body's metabolism, regulating the body's glucose metabolism, energy metabolism, lipid metabolism, and bone metabolism. Moreover, PIEZO channels are potential therapeutic targets for metabolic diseases, capable of preventing and treating obesity, diabetes and its complications, osteoporosis, metabolic syndrome, and other diseases.
Indexed as
Identifiers
42690495What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.